Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[L-DEP regimen salvage therapy for refractory primary hemophagocytic lymphohistiocytosis triggered by Epstein-Barr virus infection in 4 children].

Zhonghua er ke za zhi = Chinese journal of pediatrics - 2 May 2024

Zhao Y Z, Ma H H, Lian H Y, Wang D, Wang T Y, Zhang R

Abstract excerpt

Objective: To analyze the efficacy and safety of the L-DEP regimen (asparaginase, liposome doxorubicin, etoposide and methylprednisolone) as a salvage therapy for the refractory primary hemophagocytic lymphohistocytosis triggered by Epstein-Barr virus infection (EBV-pHLH) in children. Methods: In this retrospective case study, clinical and laboratory data before and after L-DEP regimen of 4 children diagnosed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asparaginase
Share to Epstein-Barr Virus Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Etoposide

Share to Liposomes

Share to Lymphohistiocytosis, Hemophagocytic

Share to Methylprednisolone

Share to Perforin

Share to Salvage Therapy

Source

Identifiers

PMID: 38623016
DOI: 10.3760/cma.j.cn112140-20240319-00188

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[L-DEP regimen salvage therapy for refractory primary hemophagocytic lymphohistiocytosis triggered by Epstein-Barr virus infection in 4 children].PMID 38623016Read ↗

Management of Refractory Malignancy-Associated Hemophagocytic Lymphohistiocytosis in Pediatric Patients: A Case Series of Novel Therapeutics and Treatment ChallengesSemantic proximity Read ↗

Genetic and clinical characteristics of primary hemophagocytic lymphohistiocytosis in children.Semantic proximity Read ↗

Hemophagocytic lymphohistiocytosis caused by multiple infections during primary chemotherapy for pediatric acute lymphoblastic leukemia: a case report.Semantic proximity Read ↗

Risk factors of in-hospital death in pediatric patients with hemophagocytic lymphohistiocytosis: A case-control studySemantic proximity Read ↗

Prognostic Features of Pediatric Primary Hemophagocytic Lymphohistiocytosis With CNS Involvement.Semantic proximity Read ↗

[Clinical and genetic mutation characteristics of patients with primary hemophagocytic lymphohistiocytosis and their impact on prognosis].Semantic proximity Read ↗

Hemophagocytic Lymphohistiocytosis: Lessons Learned from the Dark Side.Semantic proximity Read ↗

T cell-Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis (HLH) occurs in Non-Asians and is associated with a T cell activation state that is comparable to primary HLHSemantic proximity Read ↗

Clinical presentation and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in China: A retrospective multicenter study.Semantic proximity Read ↗

[DEMOGRAPHIC, CLINICAL AND LABORATORY CHARACTERISTICS OF CHILDREN DIAGNOSED WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH) IN THE SCHNEIDER CHILDREN'S MEDICAL CENTER BETWEEN 2004-2020].Semantic proximity Read ↗

Pediatric hemophagocytic lymphohistiocytosis.Semantic proximity Read ↗

Serious consequences of Epstein-Barr virus infection: Hemophagocytic lymphohistocytosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.